ITEM 8.01 OTHER EVENTS

On January 26, 2023, Integra LifeSciences Holdings Corporation (the "Company") entered into an accelerated share repurchase agreement with Goldman Sachs & Co. LLC to repurchase $150 million in the aggregate of the Company's outstanding shares of common stock, par value $0.01 per share. The repurchase transactions are expected to be completed in the first half of 2023.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses